Wedge Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$626K Sell
4,873
-596
-11% -$69.8K 0.01% 434
2026
Q1
$658K Buy
5,469
+497
+10% +$57.4K 0.01% 467
2025
Q4
$523K Buy
4,972
+197
+4% +$18.5K 0.01% 475
2025
Q3
$401K Buy
4,775
+34
+0.7% +$2.8K 0.01% 493
2025
Q2
$375K Buy
4,741
+272
+6% +$21.6K 0.01% 479
2025
Q1
$401K Buy
4,469
+70
+2% +$6.54K 0.01% 479
2024
Q4
$438K Hold
4,399
0.01% 476
2024
Q3
$500K Buy
4,399
+269
+7% +$32K 0.01% 463
2024
Q2
$511K Buy
+4,130
New +$532K 0.01% 450
2023
Q3
Sell
-4,350
Closed -$502K 512
2023
Q2
$502K Sell
4,350
-113
-3% -$12.8K 0.01% 473
2023
Q1
$475K Buy
4,463
+18
+0.4% +$1.94K 0.01% 320
2022
Q4
$493K Buy
4,445
+29
+0.7% +$2.96K 0.01% 315
2022
Q3
$380K Sell
4,416
-105
-2% -$9.37K 0.01% 326
2022
Q2
$412K Sell
4,521
-111
-2% -$9.84K 0.01% 325
2022
Q1
$380K Sell
4,632
-138
-3% -$10.9K 0.01% 334
2021
Q4
$366K Buy
4,770
+61
+1% +$4.86K ﹤0.01% 341
2021
Q3
$354K Buy
4,709
+25
+0.5% +$1.9K ﹤0.01% 338
2021
Q2
$364K Sell
4,684
-1,336
-22% -$99.4K ﹤0.01% 328
2021
Q1
$443K Sell
6,020
-233
-4% -$17.2K 0.01% 381
2020
Q4
$488K Buy
6,253
+202
+3% +$15.4K 0.01% 401
2020
Q3
$479K Buy
6,051
+220
+4% +$17.2K 0.01% 381
2020
Q2
$430K Buy
5,831
+45
+0.8% +$3.39K 0.01% 371
2020
Q1
$425K Hold
5,786
0.01% 358
2019
Q4
$502K Buy
5,786
+184
+3% +$15.1K 0.01% 396
2019
Q3
$450K Hold
5,602
0.01% 418
2019
Q2
$448K Buy
5,602
+1,686
+43% +$129K 0.01% 472
2019
Q1
$311K Sell
3,916
-451,228
-99% -$33.7M ﹤0.01% 519
2018
Q4
$33.2M Sell
455,144
-63,442
-12% -$4.48M 0.41% 80
2018
Q3
$35.1M Sell
518,586
-7,490
-1% -$477K 0.34% 90
2018
Q2
$30.5M Sell
526,076
-125,036
-19% -$7.05M 0.3% 106
2018
Q1
$33.8M Sell
651,112
-202,037
-24% -$10.9M 0.32% 93
2017
Q4
$45.8M Buy
853,149
+220,886
+35% +$12.2M 0.41% 66
2017
Q3
$38.6M Buy
632,263
+8,318
+1% +$504K 0.36% 85
2017
Q2
$38.2M Sell
623,945
-119,933
-16% -$7.3M 0.37% 82
2017
Q1
$45.1M Sell
743,878
-157,237
-17% -$9.54M 0.43% 81
2016
Q4
$50.6M Buy
901,115
+24,548
+3% +$1.44M 0.49% 60
2016
Q3
$52.2M Sell
876,567
-22,964
-3% -$1.34M 0.52% 50
2016
Q2
$49.4M Buy
899,531
+94,267
+12% +$5.02M 0.51% 54
2016
Q1
$40.7M Buy
805,264
+50,940
+7% +$2.49M 0.42% 62
2015
Q4
$38M Sell
754,324
-4,847
-0.6% -$244K 0.4% 84
2015
Q3
$35.8M Sell
759,171
-18,366
-2% -$976K 0.38% 85
2015
Q2
$42.2M Buy
+777,537
New +$43.6M 0.41% 88
2013
Q4
Sell
-837,153
Closed -$38M 504
2013
Q3
$38M Buy
837,153
+29,737
+4% +$1.36M 0.44% 83
2013
Q2
$35.8M Buy
+807,416
New +$36.1M 0.43% 82

Other funds holding MRK

Wedge Capital Management's MRK Position: Q2 2026 in Review

Wedge Capital Management reduced its Merck (MRK) stake by 11% in Q2 2026, selling an estimated $69.8K and leaving 4,873 shares worth $626K. The position accounts for 0.01% of the portfolio, ranked #434.

Wedge Capital Management first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. The position peaked at $52.2M in Q3 2016. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Wedge Capital Management held 4,873 shares of Merck worth $626K as of Q2 2026.
  • Wedge Capital Management sold 596 Merck shares in Q2 2026, an estimated $69.8K.
  • Merck made up 0.01% of Wedge Capital Management's portfolio in Q2 2026, its #434 holding.
  • Wedge Capital Management first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
  • Wedge Capital Management's Merck position peaked at $52.2M in Q3 2016.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.